Collaboration and License Agreements - Children's Medical Center Corporation (Details) - USD ($) $ in Millions	1 Months Ended
	May 31, 2025	Apr. 30, 2018	Sep. 30, 2025
Children Medical Center Corporation | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement
Collaboration and License Agreements
Shares issued (in shares)		15,123
Percentage of upfront payment required upon first investigational new drug study			10.00%
Children Medical Center Corporation | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Upon achievement of first licensed target
Collaboration and License Agreements
Maximum development milestone payable		$ 7.7
Children Medical Center Corporation | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Upon achievement of second licensed target
Collaboration and License Agreements
Maximum development milestone payable		3.9
Children Medical Center Corporation | Collaborative Arrangement, Transaction with Party to Collaborative Arrangement | Upon achievement of third licensed target
Collaboration and License Agreements
Maximum development milestone payable		$ 1.9
Fulcrum Therapeutics, Inc.
Collaboration and License Agreements
Proceeds from milestone payment	$ 0.6